Julie S. Barber-Rotenberg
Parker Institute for Cancer Immunotherapy(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Calcium signaling and nucleotide metabolism, Cancer, Hypoxia, and Metabolism, Sarcoma Diagnosis and Treatment, Autophagy in Disease and Therapy
Most-Cited Works
- → PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial(2022)471 cited
- → A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma(2009)441 cited
- → PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer(2018)238 cited
- → A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles(2017)200 cited
- → BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion(2022)123 cited
- → Single Enantiomer of YK-4-279 Demonstrates Specificity in Targeting the Oncogene EWS-FLI1(2012)96 cited
- → Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies(2025)61 cited
- → Pharmacokinetic modeling optimizes inhibition of the ‘undruggable’ EWS-FLI1 transcription factor in Ewing Sarcoma(2013)41 cited
- → Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors(2011)29 cited
- → Acetylation Increases EWS-FLI1 DNA Binding and Transcriptional Activity(2012)26 cited